Chemed Retained Earnings (Accumulated Deficit) 2010-2024 | CHE

Chemed retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Chemed retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $2.571B, a 12.06% increase year-over-year.
  • Chemed retained earnings (accumulated deficit) for 2023 were $2.447B, a 11.33% increase from 2022.
  • Chemed retained earnings (accumulated deficit) for 2022 were $2.198B, a 11.55% increase from 2021.
  • Chemed retained earnings (accumulated deficit) for 2021 were $1.97B, a 14.3% increase from 2020.
Chemed Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $2,447
2022 $2,198
2021 $1,970
2020 $1,724
2019 $1,426
2018 $1,226
2017 $1,039
2016 $958
2015 $866
2014 $771
2013 $686
2012 $623
2011 $547
2010 $473
2009 $403
Chemed Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $2,571
2024-03-31 $2,506
2023-12-31 $2,447
2023-09-30 $2,363
2023-06-30 $2,294
2023-03-31 $2,246
2022-12-31 $2,198
2022-09-30 $2,141
2022-06-30 $2,090
2022-03-31 $2,029
2021-12-31 $1,970
2021-09-30 $1,901
2021-06-30 $1,835
2021-03-31 $1,784
2020-12-31 $1,724
2020-09-30 $1,615
2020-06-30 $1,553
2020-03-31 $1,476
2019-12-31 $1,426
2019-09-30 $1,365
2019-06-30 $1,311
2019-03-31 $1,265
2018-12-31 $1,226
2018-09-30 $1,176
2018-06-30 $1,129
2018-03-31 $1,079
2017-12-31 $1,039
2017-09-30 $989
2017-06-30 $958
2017-03-31 $984
2016-12-31 $958
2016-09-30 $930
2016-06-30 $908
2016-03-31 $887
2015-12-31 $866
2015-09-30 $840
2015-06-30 $815
2015-03-31 $792
2014-12-31 $771
2014-09-30 $745
2014-06-30 $724
2014-03-31 $703
2013-12-31 $686
2013-09-30 $667
2013-06-30 $653
2013-03-31 $642
2012-12-31 $623
2012-09-30 $600
2012-06-30 $582
2012-03-31 $564
2011-12-31 $547
2011-09-30 $524
2011-06-30 $506
2011-03-31 $488
2010-12-31 $473
2010-09-30 $454
2010-06-30 $436
2010-03-31 $420
2009-12-31 $403
2009-09-30 $388
2009-06-30 $372
2009-03-31 $356
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.694B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00